Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018

FDA Clears Siemens Healthineers' GOKnee3D MRI Application

Application reduces scan time for MR imaging of the knee and enables clinically validated, push-button isotropic 3-D knee exam with all relevant contrasts and evaluation in all imaging planes

FDA Clears Siemens Healthineers' GOKnee3D MRI Application

February 19, 2018 — The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from Siemens Healthineers that significantly reduces the time required to perform comprehensive diagnostic exams of the knee.

GOKnee3D enables a push-button diagnostic 3-D knee exam in just 10 minutes – a substantial reduction from the standard MR knee examination.[1] Acquisition of high-resolution isotropic 3-D images enables flexible evaluation of these images in all planes, including double oblique and curved planar.

The volume acquisition of GOKnee3D enables higher scan speeds and optimal image reconstruction with better signal quality than in previous technologies. Supported by dedicated, high-channel Tim 4G knee coils as well as automated field of view adaptation based on machine learning and artificial intelligence, the MRI scanner acquires volume data of the knee joint with the push of a button.

GOKnee3D is available for the Magnetom Aera 1.5T and the Magnetom Skyra 3T MRI scanners, with eventual rollout planned for additional scanners in the company’s MRI portfolio.

For more information: www.usa.healthcare.siemens.com

Related GOKnee3D Content

Siemens Healthineers Introduces GOKnee3D MR Application

VIDEO: Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017

Notes

1. Examination time for 3T systems is 10 minutes; for a 1.5T system, up to 11 minutes. All given examination times are examination only; adjustments have been excluded. Applies to measurements only with 15channel knee coil.

 

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Videos | Enterprise Imaging | July 09, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison
Videos | Enterprise Imaging | July 08, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison